The RESCUE and RESTORE trials: RNS60 after EVT in LVO strokes

Supurna Ghosh, PhD, Revalesio Corporation, Tacoma, WA, comments on the RESCUE trial (NCT04693715), a proof-of-concept Phase II study that investigated the safety of RNS60 after endovascular treatment (EVT) for large vessel occlusion (LVO) strokes. The study showed there were no concerns around safety and an indication of drug efficacy. These findings have influenced the design of the larger Phase IIb/III RESTORE trial, which will enroll patients with LVO stroke within 12 hours of symptom onset and assess the efficacy of RNS60 in preventing infarct growth and improving outcomes. This interview took place at the 77th American Academy of Neurology (AAN) Annual Meeting in San Diego, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Тэги:

#Speaker:_Supurna_Ghosh #Institution:_Revalesio_Corporation #Event:_AAN_2025 #Format:_Interview #Subject:_Stroke #Subject:_Acute_Ischemic_Stroke #Field:_Treatment #Field:_Trial_Updates #Medicines:_RNS60 #Trial:_RESTORE #Trial:_RESCUE #NCT04693715 #EVT #endovascular_thrombectomy #LVO_stroke #large_vessel_occlusion_stroke #LVO

Скачать видео